pubmed-article:10934691 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C0242510 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C0086409 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:10934691 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
pubmed-article:10934691 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:10934691 | pubmed:dateCreated | 2000-10-3 | lld:pubmed |
pubmed-article:10934691 | pubmed:abstractText | Hypertension guidelines emphasize the selection of antihypertensive treatment on the basis of absolute cardiovascular risk. Moreover, compelling and possible indications for each antihypertensive drug class are recommended for patients with other concomitant conditions. The aim of the present study was to analyze the relationship between the cardiovascular risk profile and co-morbid conditions on antihypertensive drug class use. | lld:pubmed |
pubmed-article:10934691 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10934691 | pubmed:language | spa | lld:pubmed |
pubmed-article:10934691 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10934691 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10934691 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10934691 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10934691 | pubmed:month | Jun | lld:pubmed |
pubmed-article:10934691 | pubmed:issn | 0025-7753 | lld:pubmed |
pubmed-article:10934691 | pubmed:author | pubmed-author:RuilopeL MLM | lld:pubmed |
pubmed-article:10934691 | pubmed:author | pubmed-author:CocaAA | lld:pubmed |
pubmed-article:10934691 | pubmed:author | pubmed-author:Luque-OteroMM | lld:pubmed |
pubmed-article:10934691 | pubmed:author | pubmed-author:de la... | lld:pubmed |
pubmed-article:10934691 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10934691 | pubmed:day | 10 | lld:pubmed |
pubmed-article:10934691 | pubmed:volume | 115 | lld:pubmed |
pubmed-article:10934691 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10934691 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10934691 | pubmed:pagination | 41-5 | lld:pubmed |
pubmed-article:10934691 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:meshHeading | pubmed-meshheading:10934691... | lld:pubmed |
pubmed-article:10934691 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10934691 | pubmed:articleTitle | [Relationship between cardiovascular risk profile and anti-hypertensive drug use. GEDEC (Spanish group of cardiovascular studies]. | lld:pubmed |
pubmed-article:10934691 | pubmed:affiliation | Unidad de Hipertensión, Hospital Clínic, Barcelona. iserte@medicina.ub.es | lld:pubmed |
pubmed-article:10934691 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10934691 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:10934691 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10934691 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10934691 | lld:pubmed |